End Stage Cardiac Failure
Differential regulation of two types of intracellular calcium release channels during end stage heart failure
... The molecular basis of human heart failure is unknown. Alterations in calcium homeostasis have been observed in failing human heart muscles. Intracellular calcium-release channels regulate the calcium flux ...
8
Reversal of end stage heart failure in juvenile hemochromatosis with iron chelation therapy: a case report
... acidosis. Cardiac magnetic resonance imaging (cMRI) completed 2 weeks post BiVAD explant demonstrated normal biventricular systolic function but a myocardial T2* time of ...
6
Development and Application of Gadolinium Free Cardiac Magnetic Resonance Fibrosis Imaging for Multiscale Study of Heart Failure in Patients with End Stage Renal Disease
... suitable cardiac fibrosis diagnostic has limited the understanding of heart failure in the setting of ESRD and obstructed development and testing of potential therapies in this unique ...sudden ...
165
Impact of Mitral Valve Repair in Patients with End Stage Congestive Heart Failure
... study. Cardiac outcome parameters such as LVEF, left ventricular internal diameter in diastole (LVIDd), NYHA class and mitral regurgitation before and after surgery were retrospec- tively ...in cardiac ...
5
Cardiac retransplantation is an efficacious therapy for primary cardiac allograft failure
... failing, end-stage cardiac allografts ...for end-stage heart failure following a cardiac transplant remains car- diac ...are cardiac retransplants[11]. The ...
5
Altered sarcoplasmic reticulum Ca2(+) ATPase gene expression in the human ventricle during end stage heart failure
... experimental cardiac hypertrophy and ...human end-stage heart failure, we compared the SR Ca2(+)-ATPase mRNA levels in left (LV) and right ventricular (RV) specimens from 13 patients ...
6
Myostatin and IGF I signaling in end stage human heart failure: a qRT PCR study
... of cardiac disease ...both cardiac and skeletal muscles, although exercise training lead to a reduction of myostatin levels only in skeletal muscles but not in serum of patients with chronic heart ...
9
Incidence of sudden cardiac death in adults with end-stage renal disease: a systematic review and meta-analysis
... each stage of study and reasons for ineligibility, propor- tion of eligible participants described, evidence of con- secutive or random sampling, clear descriptions of inclusion criteria and sources and methods of ...
9
Cardiac Arrhythmias in Patients with End Stage Renal Disease (ESRD) on Hemodialysis; Recent Update and Brief Literature Review
... Different complications might happen with the traditional implantable cardioverter defibrillator (ICD). Preservation of the peripheral and the central veins in chronic kidney disease is important for successful ...
5
Cardiac remodeling in postischemic end stage human hearts: Involvement of extracellular matrix and angiogenesis related molecules
... influences cardiac stem-cell differentiation and ...examined cardiac tissue samples from 21 explanted human hearts and 10 non-failing hearts before ...of cardiac failure by contributing to ...
9
Adropin and irisin: New biomarkers of cardiac status in patients with end-stage renal disease? A preliminary study
... hepatic failure, hematologic disorders, active autoimmune disease or neoplasm, history of acute infection within the previ- ous 7 days, and MI during the last 6 ...
7
Expression of dihydropyridine receptor (Ca2+ channel) and calsequestrin genes in the myocardium of patients with end stage heart failure
... controls). There was no difference in the level of cardiac calsequestrin mRNA between the HF patients and normal controls. In contrast, the level of mRNA encoding the DHP receptor was decreased by 47% (P less than ...
10
Advanced interventional cardiac procedures and perioperative care required to prevent the epidemic of end-stage heart disease in Sri Lanka
... End stage heart failure often carries a substantially worse prognosis than some cancers in terms of morbidity and ...therapy, cardiac synchronization therapy+/- defibrillators, reversal of few ...
7
The Parathyroid Glands and Parathyroid Surgery in End Stage Renal Failure
... required more IV calcium, with their hospital stay significantly longer. The most significant change however was a potassium elevation of > 6.00mmol/L observed in 81.25% (n=13/16) of these patients, even as soon as ...
179
End-stage human chronic heart failure is the common final
... to study this pathophysiologic situation, and these usually are not able to mimic the slowly developing human situation. Therefore, most studies concerning the mechanism of re- duced function are carried out in tissue ...
8
Pathogenesis of cardiac graft failure in children
... failed cardiac grafts show no fibrofatty morphology at the time of transplantation, acquired fibrofatty changes in the graft are thought to be due to inflammation, rejection, infection, or drug therapy side ...
5
Hyponatremia in Congestive Cardiac Failure
... The aim of the study is to find the prevalence, clinical profile of dysnatremia, impact of dysnatremia in morbidity and in hospital mortality in congestive cardiac failure. Left ventricular function and ...
5
A cost analysis of hemodialysis and peritoneal dialysis for the management of end-stage renal failure at an academic hospital, Pretoria, South Africa
... HIV was the third most common comorbidity of renal failure in our study. This is expected since HIV is highly prevalent in South Africa, endorsing the need to look closely at this co-morbidity, especially among ...
11
Effects of a transitional palliative care model on patients with end stage heart failure: study protocol for a randomized controlled trial
... the end stage. End-stage heart failure is resistant to medical therapy [1], and this group of patients experi- ences a marked reduction in health-related quality of life [6, 12], ...
9
Pharmacovigilance as a tool for safety and monitoring: a review of general issues and the specific challenges with end-stage renal failure patients
... with end-stage renal disease and often other comorbidities such as diabetes, hypertension, and cardiovascular disease – are a population with significant treatment ...
8